Examination of statistical methods for evaluating treatment efficacy in patients with dilated cardiomyopathy: A retrospective observational study.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1050260078

Enrollment

166

Registered

2026-06-12

Start date

2026-06-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dilated Cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with dilated cardiomyopathy who meet one of the following criteria: 1.Patients registered in the heart failure registry (Japan Heart Failure Model; JHFM) 2.Patients enrolled in the following clinical trial: 1)Development of treatment for severe heart failure using autologous myoblast sheet 2)Exploratory study for dilated cardiomyopathy using YS0001 3)Implement of Autologous Skeletal Myoblast Cell Sheet Transplantation for Dilated Cardiomyopathy aiming Precision Medicine 4)Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for dilated cardiomyopathy

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Period from the date of echocardiography measurement at the time of LVEF evaluation to the occurrence of death.	—

Secondary

Measure	Time frame
The period from the date of the echocardiogram measurement at the time of LVEF evaluation to the occurrence of a cardiac event.	—

Contacts

Public ContactMasao Sasai

The University of Osaka Graduate School of Medicine

saisentan@tissue.med.osaka-u.ac.jp+81-6-6879-3154

Outcome results